| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL PAPER |
a Departments of Surgical Oncology, b Thoracic and Cardiovascular Surgery, c Neurosurgery, and d Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Correspondence: S. Eva Singletary, M.D., FACS, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, Texas 77030-4095, USA. Telephone: 713-792-6937; Fax: 713-792-2225; e-mail: esinglet{at}mdanderson.org
Although metastatic breast cancer is widely believed to carry a grim prognosis, treatment developments over the past 25 years have greatly improved survival outcomes in these patients. In selected cases, aggressive treatment approaches may occasionally result in long-term survival of 15 years or more. This review considers the role of surgery in the treatment of single or multiple metastatic lesions restricted to one site. For each site, available literature from 19922002 was assessed to determine the role of surgery on survival outcomes and to determine appropriate criteria for selecting the best candidates for surgery. For lung, liver, brain, and sternum metastases, the use of surgery with or without adjuvant therapy resulted in greater median survival times and 5-year survival rates. The best candidate for surgery had no evidence of additional metastatic disease, good performance status, and a long disease-free interval after treatment of the primary tumor. Current treatment standards for breast cancer follow-up do not include imaging studies other than mammography. The addition of chest x-rays as part of routine follow-up should be considered as a cost-effective approach for early assessment of metastases to the lung or sternum that may be appropriate for surgical excision.
This article has been cited by other articles:
![]() |
R. C. Fields, D. B. Jeffe, K. Trinkaus, Q. Zhang, C. Arthur, R. Aft, J. R. Dietz, T. J. Eberlein, W. E. Gillanders, and J. A. Margenthaler Surgical Resection of the Primary Tumor is Associated with Increased Long-Term Survival in Patients with Stage IV Breast Cancer after Controlling for Site of Metastasis Ann. Surg. Oncol., December 1, 2007; 14(12): 3345 - 3351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gnerlich, D. B. Jeffe, A. D. Deshpande, C. Beers, C. Zander, and J. A. Margenthaler Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988 2003 SEER Data Ann. Surg. Oncol., August 1, 2007; 14(8): 2187 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rapiti, H. M. Verkooijen, G. Vlastos, G. Fioretta, I. Neyroud-Caspar, A. P. Sappino, P. O. Chappuis, and C. Bouchardy Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at Diagnosis J. Clin. Oncol., June 20, 2006; 24(18): 2743 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V. Babiera, R. Rao, L. Feng, F. Meric-Bernstam, H. M. Kuerer, S. E. Singletary, K. K. Hunt, M. I. Ross, K. M. Gwyn, B. W. Feig, et al. Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary Tumor Ann. Surg. Oncol., June 1, 2006; 13(6): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vlastos, D. L. Smith, S. E. Singletary, N. Q. Mirza, T. M. Tuttle, R. J. Popat, S. A. Curley, L. M. Ellis, M. S. Roh, and J.-N. Vauthey Long-term Survival After An Aggressive Surgical Approach in Patients With Breast Cancer Hepatic Metastases Ann. Surg. Oncol., September 1, 2004; 11(9): 869 - 874. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |